Award
National Cancer Institute 5R01CA255609-06
Targeting tumor repopulation and the immune microenvironment to overcome chemoresistance
Recipient
Methodist Hospital Research Institute
Award Amount
$452,797.00
Ceiling
$452,797.00
Awarded
August 01, 2025
Identifier
5R01CA255609-06
NIH awarded a research grant to Methodist Hospital Research Institute to study mechanisms of tumor repopulation and immune response in bladder cancer to improve chemotherapy effectiveness.
Description
This NIH research grant project aims to investigate tumor repopulation and immune microenvironment mechanisms to overcome chemoresistance in muscle-invasive bladder cancer, with the goal of identifying therapeutic targets to improve chemotherapy response.